Dr. Jianqin Lu is an Assistant Professor and Director of Pharmaceutics and Pharmacokinetics Track at R. Ken Coit College of Pharmacy (Ranked #5 in NIH funding and #20 in US News and World Report), The University of Arizona, a member of the Association of American Universities (AAU), a distinction to only 69 North America's premier research institutions. Dr. Lu’s research work has been published in Nature Nanotechnology, Nature Communications, Biomaterials, etc, and has resulted in a Maximizing Investigators' Research Award (MIRA) (R35, $1.9 Million) from National Institute of Health (NIH)/National Institute of General Medical Sciences (NIGMS), an R01 ($1.72 Million) from NIH/National Cancer Institute (NCI), a Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Grant in Drug Delivery ($100,000), and several pilot and seed grants (~$200,000) from the State of Arizona and NIH-sponsored The Southwest Environmental Health Sciences Center (SWEHSC). The overarching goal of the Lu lab strives to develop innovative, safe, and efficacious therapeutics at the interface of drug delivery, synthetic chemistry, pharmaceutics, nanotechnology, and tumor immunology to address the pressing unmet needs in current cancer, heart, and Alzheimer's diseases therapy and prevention. Visit Lu lab website at: https://wonderfulearth.wixsite.com/jianqinlu

Two postdoc positions are available. One postdoc candidate should be equipped with strong medicinal and bioconjugation chemistry skill, and the ability to design and synthesize novel drug conjugates. One postdoc candidate will focus on drug delivery and nanomedicine (liposome, polymeric and core-shell nanoparticles), in vitro and in vivo characterizations and therapeutic efficacy studies.

Outstanding UA benefits include health, dental, vision, and life insurance; paid vacation, sick leave, and holidays; UA/ASU/NAU tuition reduction for the employee and qualified family members; access to UA recreation and cultural activities; and more!

The University of Arizona has been recognized for our innovative work-life programs. For more information about working at the University of Arizona and relocations services, please click here .

• Synthesize and characterize novel prodrug conjugate; Prepare and characterize the nanoformulations (e.g., liposome and polymeric nanoparticles) Cell culture; Pharmacokinetics and Biodistribution.
• In vivo antitumor efficacy studies.
• Present research results and literature in group meetings and departmental seminars.
• Prepare and write manuscripts for publication.

Knowledge, Skills, and Abilities:

• Demonstrate track record of scholarly ability.
• Strong problem-solving and syntetic skills.
• Effective communication and collaboration with group members and other labs.

• PhD in Organic/Medicinal Chemistry and Pharmaceutical Sciences, or relevant scientific field.

• High impact publications in Organic/Medicinal Chemistry, or Drug Delivery/Nanomedicine.
• High impact publications in Organic/Medicinal Chemistry or relevant scientific field.